Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Agnico Beats Again With Costs Under Control

% of readers think this story is Fact. Add your two cents.


Source: Adrian Day 08/17/2026

Global Analyst Adrian Day reviews more earnings reports from a top gold company and one of his favorite high-yield companies.

Agnico Eagle Mines Ltd. (AEM:TSX; AEM:NYSE) saw a small production beat when it reported its second-quarter results, which, together with lower-than-expected operating costs, saw record Free Cash Flow and a record capital return (dividend and share buybacks), despite an 8% drop in the average gold price for the quarter and oil over $100/bbl. Several mines had record quarterly output, including Detour, Kittila, and Meliadine. All-in Sustaining Costs (AISC) at $1,459/oz were helped by the high U.S. dollar (reducing costs outside the U.S.) as well as strong by-product prices.

The company reiterated its full-year production guidance, albeit at the lower end, despite the suspension of mining at the Barnat pit. Some 40% of the $3.5 billion of operating cash flow in the first half was allocated to ongoing capital investments (including acquisitions), while 30% was returned in the form of dividends and share buybacks.

Looking ahead, five development projects are advancing, including the shaft sinking at Odyssey (underground Malartic), Upper Beaver, and Hope Bay, ensuring a steady pipeline in the years ahead.

Agnico is best in class among major gold producers, and a Buy.

Fortuna To Go Ahead With Next Stage of Growth

Fortuna Mining Corp. (FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE) approved a 30% capacity increase at its Séguéla mine in Côte d’Ivoire.

The expansion, which will also see improved recoveries to nearly 95%, will be funded by current liquidity and cash flow, with construction expected to begin later this year. The Sunbird underground deposit at the mine was also approved, with mining expected to commence in the second quarter of 2027.

The expansion approval had been expected.

Among the mid-tier producers, Fortuna is a strong buy.

Ares Reports Slightly Down Quarter, but Metrics Still Strong

Ares Capital Corp. (ARCC:NASDAQ) reported a slightly down quarter, though still strong, with an optimistic outlook. Earnings remained just below the dividend, though spillover income supports the payment, while management is confident that modest leverage and long-term earnings power support the dividend over time. Widening spreads and new investments suggest the potential for earnings, once again, to exceed the dividend in the period ahead.

The company has spillover income equivalent to almost three-quarters of dividend payments. The quarter was poor for closings on new loans, but activity picked up towards the end of the quarter, with an improved pipeline of opportunities, with higher fees and stronger terms, particularly in the “upper-middle market” where there is less competition.

Credit Ranking Better Than History, Better Than Sector

Credit remains solid overall, despite nonaccruals edging higher, though at 2.4% at cost, they are still well below Ares’ post-GFC historical levels (3%) and the BDC sector’s average (approximately 4%). Companies rated in the lowest two of four grades are again below Ares’ longer-term average level and also “meaningfully lower” than those rated 4, which indicates companies outperforming original expectations. Declining marks on some loans in the quarter led to a small decline in net asset value, down 1.2% on the prior quarter.

Ares is in a strong position, with $6 billion in available liquidity. It repaid $1 billion on unsecured notes, though it also raised additional debt of almost $1.2 billion, lowering borrowing costs, extending maturities, and diversifying funding sources. Leverage at moderately over 1x is low, and in the middle of Ares’s own conservative range. The largest and highest-rated BDC, it is well diversified (619 portfolio companies, with no single investment over 1.3% of the portfolio). Trading slightly below NAV, and yielding over 10% (close to the high, other than during the depths of COVID, back to GFC).

For long-term income-oriented investors, Ares is a Buy.

TOP PICKS this week, in addition to the above OR Royalties (OR:TSX; OR:NYSE), Royal Gold Inc. (RGLD:NASDAQ), Pan American Silver Corp. (PAAS:TSX; PAAS:NYSE), and Lara Exploration Ltd. (LRA:TSX.V).

[SMNLINSERT]

Important Disclosures:

  1. Adrian Day: I, or members of my immediate household or family, own securities of: All. My company has a financial relationship with: None. My company has purchased stocks mentioned in this article for my management clients: All. I determined which companies would be included in this article based on my research and understanding of the sector.
  2. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
  3. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Adrian Day Disclosures

Adrian Day’s Global Analyst is distributed for $990 per year by Investment Consultants International, Ltd., P.O. Box 6644, Annapolis, MD 21401. (410) 224-8885. www.AdrianDayGlobalAnalyst.com. Publisher: Adrian Day. Owner: Investment Consultants International, Ltd. Staff may have positions in securities discussed herein. Adrian Day is also President of Global Strategic Management (GSM), a registered investment advisor, and a separate company from this service. In his capacity as GSM president, Adrian Day may be buying or selling for clients securities recommended herein concurrently, before or after recommendations herein, and may be acting for clients in a manner contrary to recommendations herein. This is not a solicitation for GSM. Views herein are the editor’s opinion and not fact. All information is believed to be correct, but its accuracy cannot be guaranteed. The owner and editor are not responsible for errors and omissions. © 2023. Adrian Day’s Global Analyst. Information and advice herein are intended purely for the subscriber’s own account. Under no circumstances may any part of a Global Analyst e-mail be copied or distributed without prior written permission of the editor. Given the nature of this service, we will pursue any violations aggressively.

( Companies Mentioned: AEM:TSX; AEM:NYSE, ARCC:NASDAQ, FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE, )


Source: https://www.streetwisereports.com/article/2026/08/17/agnico-beats-again-with-costs-under-control.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login